Repaglinide
- Product NDC
- 0574-0241
- 11-digit product format
- 005740241
- Labeler code
- 0574
- Product ID
- 0574-0241_aa4d9497-0357-4ef9-bb01-9ec5b0401a05
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- REPAGLINIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Padagis US LLC
- Application
- ANDA201189
- Marketing category
- ANDA
- Marketing start
- 2014-01-22
- Marketing end
- 0000-00-00
- Substance
- REPAGLINIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Glinide [EPC],Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0574-0241-01 | 00574024101 | 100 TABLET in 1 BOTTLE (0574-0241-01) | 100 tablet | 2014-01-22 | 0000-00-00 | No | No | Current |